ZyVersa Therapeutics Financial Ratios for Analysis 2021-2024 | ZVSA

Fifteen years of historical annual and quarterly financial ratios and margins for ZyVersa Therapeutics (ZVSA).

Annual Data

Metric Name
Current Ratio
Long-term Debt / Capital
Debt/Equity Ratio
Gross Margin
Operating Margin
EBIT Margin
EBITDA Margin
Pre-Tax Profit Margin
Net Profit Margin
Asset Turnover
Inventory Turnover Ratio
Receiveable Turnover
Days Sales In Receivables
ROE - Return On Equity
Return On Tangible Equity
ROA - Return On Assets
ROI - Return On Investment
Book Value Per Share
Operating Cash Flow Per Share
Free Cash Flow Per Share
202320222021
0.330.780.06
---
---0.71
---
---
---
---
---
---
---
---
---
---
-887.60-14.1763.00
1,29811563.00
-444.50-11.92-717.84
-887.60-14.1763.00
27.333,863-185.65
-89.44-189.48-73.44
-89.44-189.48-73.44

Quarterly Data

Metric Name
Current Ratio
Long-term Debt / Capital
Debt/Equity Ratio
Gross Margin
Operating Margin
EBIT Margin
EBITDA Margin
Pre-Tax Profit Margin
Net Profit Margin
Asset Turnover
Inventory Turnover Ratio
Receiveable Turnover
Days Sales In Receivables
ROE - Return On Equity
Return On Tangible Equity
ROA - Return On Assets
ROI - Return On Investment
Book Value Per Share
Operating Cash Flow Per Share
Free Cash Flow Per Share
2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-30
0.030.060.300.330.170.110.330.78-----
-------------
-------------
-------------
-------------
-------------
-------------
-------------
-------------
-------------
-------------
-------------
-------------
-34.17-32.06-25.19-120.43-14.74-391.36-3.65-4.69-----
20.6627.5638.0717626.1573123.8137.98-----
-12.36-14.20-13.06-60.31-8.84-245.45-3.08-3.95-----
-34.17-32.06-25.19-120.43-14.74-391.36-3.65-4.69-----
6.5410.3213.4427.551582963,6853,863-----
-6.41-6.82-6.05-89.44-61.17-97.98-176.52-189.50-15.60-9.98-5.410.000.00
-6.41-6.82-6.05-89.44-61.17-97.98-176.52-189.50-15.60-9.98-5.41--